Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
Histologic observation of ovarian mucinous tumors suggests that there is a multistep transition through the accumulation of genetic alterations. We analyzed loss of heterozygosity (LOH) and replication error (RER) on TP53 and D17S855 as well as K-ras point mutations of the heterogeneous histologic areas of the same tumor in 26 cases of ovarian mucinous tumor. The laser capture microdissection (LCM) technique has been applied to the study of K-ras point mutation in 10 cases. As for genetic alterations for LOH or RER on TP53 and D17S855, 2 (1 borderline tumor and 1 carcinoma) of 14 cases and 4 (1 borderline tumor and 3 carcinomas) of 12 cases, respectively, showed genetic heterogeneities in different histologic areas. Six (2 borderline tumors and 4 carcinomas) of 18 cases showed heterogeneity of K-ras point mutation in the different histologic areas of the same tumor, and 5 (1 cystadenoma with Brenner tumor component, 2 borderline tumors, and 2 carcinomas) of 10 cases showed heterogeneous K-ras mutation pattern in the same tumor when the LCM technique was used. Atypical areas tended to show K-ras point mutations frequently. Out of 3 cases of mixed mucinous cystadenoma and Brenner tumor, 1 case showed K-ras point mutation in the Brenner tumor area but not in the area of mucinous cystadenoma. These preliminary results suggest that a subset of ovarian mucinous tumors occur through multistep carcinogenesis and show that LCM is useful for molecular pathologic studies.
Takeshima
Y
Y
Second Department of Pathology, Hiroshima University School of Medicine, Hiroshima, Japan.
Amatya
V J
VJ
Daimaru
Y
Y
Nakayori
F
F
Nakano
T
T
Inai
K
K
D000328:Adult; D000368:Aged; D001948:Brenner Tumor / Q000175:diagnosis / Q000235:genetics / Q000473:pathology; D018282:Cystadenocarcinoma, Mucinous / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D018291:Cystadenoma, Mucinous / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D004210:Dissection / Q000379:methods*; D005260:Female; D011905:Genes, ras; D014644:Genetic Variation; D006801:Humans; D007834:Lasers; D019656:Loss of Heterozygosity; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D017354:Point Mutation